| Target Price | $3.06 |
| Price | $6.88 |
| Deviation |
55.49%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target GT Biopharma Inc 2027 .
The average GT Biopharma Inc target price is $3.06.
This is
55.49%
register free of charge
$3.15
54.18%
register free of charge
$3.03
55.93%
register free of charge
|
|
| A rating was issued by 7 analysts: 6 Analysts recommend GT Biopharma Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the GT Biopharma Inc stock has an average upside potential 2027 of
55.49%
register free of charge
|
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| P/E | negative |
3 Analysts have issued a GT Biopharma Inc forecast for earnings per share. The average GT Biopharma Inc EPS is
This results in the following potential growth metrics and future valuations:
GT Biopharma Inc...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Roth MKM |
Locked
➜
Locked
|
Locked | Dec 02 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Roth MKM:
Locked
➜
Locked
|
Dec 02 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


